Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Northway Biotechnorthwaybiotech.comNorthway Biotech is an end-to-end contract development and manufacturing organization (CDMO) focused on the development and manufacturing of protein-based biologics and gene therapies, offering development and cGMP manufacturing from preclinical to commercial stages with regulatory compliance. They operate three facilities across the EU and US (including Vilnius, Lithuania and Waltham, Massachusetts) with capabilities in cell line development, process development, analytical methods development, formulation development, viral clearance studies, and drug substance and drug product manufacturing for mammalian and microbial systems. Backed by over 20 years of experience and a vertically integrated service model, Northway Biotech aims to rapidly execute multiple projects and expand ATMP manufacturing capacity globally.
Sources
northwaybiotech.com shapes more of what AI says about Northway Biotech than any other source, at 91% of its citations.
umassmed.edu
The market map
Cold Chain & Hazmat Logistics Services →Where AI ranks Northway Biotech
Excerpts where Northway Biotech appeared in the AI's answer
Northway Biotech - Conducts cGMP mammalian and microbial cell banking with dedicated risk-mitigation protocols that store portions of client MCBs offsite
Northway Biotech : Integrates cGMP cell banking with risk-mitigation protocols that store a portion of a client's MCB and working cell banks (WCBs) offsite in vapor-phase liquid nitrogen or ultra-low mechanical freezers.
